Oteseconazole
Vivjoa (oteseconazole) is an oral antifungal medication specifically approved to reduce the incidence of recurrent vulvovaginal candidiasis (chronic or repeated yeast infections) in women who are not of reproductive potential. It works by inhibiting an enzyme essential for fungal cell membrane synthesis, helping prevent the overgrowth of Candida yeast that causes these infections. This medication is available by prescription only and represents a treatment option for women who experience frequent recurrence of vaginal yeast infections.
Vivjoa is a prescription antifungal used to prevent recurrent vaginal yeast infections in women who are not of reproductive potential.
Key facts at a glance
- RxNorm
- 2602583
- Generic
- Vivjoa
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Vivjoa is indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC), defined as three or more symptomatic episodes within a 12-month period, in women who are not of reproductive potential.
Vivjoa is an azole antifungal that selectively inhibits fungal cytochrome P450 enzymes, disrupting ergosterol synthesis. Ergosterol is an essential component of the fungal cell membrane, and its depletion weakens the cell membrane, preventing Candida yeast from proliferating.
Vivjoa is contraindicated in women of reproductive potential due to its long half-life and potential for fetal harm. Common side effects may include headache and nausea. Patients should take the medication exactly as prescribed by their healthcare provider, with the dosing schedule consisting of an initial loading phase followed by a maintenance regimen.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy